Venue | : | LOTUS SUITE 5-7 |
During the long processes of human cultural evolution, population dispersal, and subsequent inter-population contact and conflict, several distinct transitions in human ecology and inter-population interactions have changed profoundly the patterns of infectious disease in human populations. As we move further into the 21st century, the spread and increased lability of infectious diseases, new and old, reflects the impacts of demographic, environmental, technological and other rapid changes in human ecology. Climate change, one of the global environmental changes under way, is anticipated to have a wide range of increased impacts upon the occurrence of infectious diseases affecting human, animal, and plant populations.
Climate and weather patterns affect the distribution and risk of many infectious diseases, including vector-borne diseases such as malaria, Rift Valley fever, plague, encephalitis and dengue fever. Weather patterns also affect the distribution of food- and water-borne diseases and emerging infectious diseases such as West Nile virus, Hantavirus, and Ebola hemorrhagic fever and the sporulation of diseases such as anthrax and other clostridia.
The effect of climate variability on infectious diseases is determined largely by the unique transmission cycle of each pathogen. Transmission cycles that require a vector or non-human host are more susceptible to external environmental influences than those diseases which include only the pathogen and human. Important environmental factors include temperature, altitude, precipitation and humidity. Several possible transmission components include pathogen nature (viral, bacterial, etc.), vector (mosquito, snail, etc.), abiotic physical vehicle (water, soil, etc.), non-human reservoir (mice, deer, etc.), and human host.
Humans are more than passive recipients of climate change-induced health effects. We can play a significant and active role through proactive adaptation and mitigation measures in order to control and alleviate the negative health impacts of climate change. The magnitude of changes in climate variables varies across the globe, posing more challenges and stresses for some groups, societies and populations than others. Given the same magnitude of climate change, some population groups and areas are more vulnerable to the elevated risks due to their lack of the ability and resources to effectively respond to the stresses and challenges, including nutrition, immune status, and access to goods, services, and clean water. Inadequate public policies may be perpetuating the marginalization that increases vulnerability to adverse events or change processes. Given that infectious diseases do not confine themselves within a vulnerable population group, these diseases pose a shared global risk and require a coordinated global effort to reduce their vulnerability to climate change-induced health risks. Importantly, human vulnerability to the changing risks for infectious diseases driven by climate change may be altered through proper adaptation measures. Examples include the continuous evolution of public health programmes, the cyclical re-allocation of financial and health care resources and the pre-emptive alteration of policies following scientific projection of spatial–temporal changes in health risk for human infectious diseases. Early warning systems based on such projections have been proven effective in helping societies take proactive measures to prevent or alleviate the possible health impacts.
Team Leader Health and Innovative Financing
United Nation Development Programme
United States of America
Professor
Department of Global Health, University of Washington
United States of America
Technical Specialist, Climate Change Adaptation
United Nations Development Programme
Thailand
Coordinator
Climate Change & Health Promotion Unit, Ministry of Health & Family Welfare
Bangladesh
Chief/Senior Research Officer
Nepal Health Research Council (NHRC), Government of Nepal
Nepal
Senior Research Associate, Planetary Health Science Policy
Cornell University
United States of America
Executive Director
GLOBAL HEALTH ASIA INSTITUTE
Thailand
Assistant Professor Biology and Control of Disease Vectors
Laboratory of Entomology, Wageningen University
Netherlands